Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

amn healthcare services inc. - AMN

AMN

Close Chg Chg %
25.71 0.14 0.53%

Closed Market

25.84

+0.14 (0.53%)

Volume: 603.13K

Last Updated:

Nov 22, 2024, 3:59 PM EDT

Trade Now

Company Overview: amn healthcare services inc. - AMN

AMN Key Data

Open

$25.78

 Day Range

25.63 - 26.36

52 Week Range

23.39 - 80.18

 Market Cap

$978.49M

Shares Outstanding

38.07M

 Public Float

37.78M

Beta

0.13

 Rev. Per Employee

N/A

P/E Ratio

18.51

 EPS

$1.39

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.28M

  

AMN Performance

1 Week
 
 8.44%
 
1 Month
 
 -35.22%
 
3 Months
 
 -51.85%
 
1 Year
 
 -61.89%
 
5 Years
 
 -56.90%
 

AMN Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 9
Full Ratings ➔

About amn healthcare services inc. - AMN

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to healthcare facilities across the nation. Its workforce solutions include managed services programs and recruitment process outsourcing. It operates through the following segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment includes travel nurse staffing, rapid response nurse staffing and labor disruption, allied staffing, local staffing, and revenue cycle solutions businesses. The Physician and Leadership Solutions segment offers locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement businesses. The Technology and Workforce Solutions segment focuses on language interpretation, vendor management systems, workforce optimization, recruitment process outsourcing, education, credentialing and flex pool management businesses. The company was founded on November 10, 1997 and is headquartered in Dallas, TX.

AMN At a Glance

AMN Healthcare Services, Inc.
2999 Olympus Boulevard
Dallas, Texas 75019
Phone 1-866-871-8519 Revenue 3.79B
Industry Personnel Services Net Income 210.68M
Sector Commercial Services Employees 3,585
Fiscal Year-end 12 / 2024
View SEC Filings

AMN Valuation

P/E Current 18.515
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 13.983
Price to Sales Ratio 0.777
Price to Book Ratio 3.406
Price to Cash Flow Ratio 7.915
Enterprise Value to EBITDA 8.452
Enterprise Value to Sales 1.119
Total Debt to Enterprise Value 0.318

AMN Efficiency

Revenue/Employee 1,056,974.616
Income Per Employee 58,766.806
Receivables Turnover 5.076
Total Asset Turnover 1.251

AMN Liquidity

Current Ratio 1.283
Quick Ratio 1.283
Cash Ratio 0.084

AMN Profitability

Gross Margin 28.889
Operating Margin 8.995
Pretax Margin 7.503
Net Margin 5.56
Return on Assets 6.958
Return on Equity 22.474
Return on Total Capital 9.657
Return on Invested Capital 10.353

AMN Capital Structure

Total Debt to Total Equity 162.439
Total Debt to Total Capital 61.896
Total Debt to Total Assets 44.38
Long-Term Debt to Equity 161.477
Long-Term Debt to Total Capital 61.53
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Amn Healthcare Services Inc. - AMN

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
2.39B 3.98B 5.24B 3.79B
Sales Growth
+7.72% +66.45% +31.60% -27.73%
Cost of Goods Sold (COGS) incl D&A
1.69B 2.78B 3.66B 2.69B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
94.19M 103.70M 137.11M 160.93M
Depreciation
28.90M 40.68M 54.03M 71.17M
Amortization of Intangibles
65.29M 63.02M 83.08M 89.76M
COGS Growth
+10.25% +63.79% +31.84% -26.37%
Gross Income
699.01M 1.21B 1.58B 1.09B
Gross Income Growth
+2.05% +72.88% +31.05% -30.88%
Gross Profit Margin
+29.20% +30.33% +30.20% +28.89%
2020 2021 2022 2023 5-year trend
SG&A Expense
544.85M 730.45M 939.51M 753.81M
Research & Development
- - - -
-
Other SG&A
544.85M 730.45M 939.51M 753.81M
SGA Growth
+8.78% +34.07% +28.62% -19.77%
Other Operating Expense
- - - -
-
Unusual Expense
- 4.90M (2.93M) (10.07M)
EBIT after Unusual Expense
149.26M 478.00M 647.10M 350.93M
Non Operating Income/Expense
- - - -
-
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
57.74M 34.08M 40.40M 66.64M
Interest Expense Growth
+103.12% -40.98% +18.55% +64.97%
Gross Interest Expense
57.74M 34.08M 40.40M 66.64M
Interest Capitalized
- - - -
-
Pretax Income
91.52M 443.92M 606.70M 284.29M
Pretax Income Growth
-38.36% +385.04% +36.67% -53.14%
Pretax Margin
+3.82% +11.14% +11.57% +7.50%
Income Tax
20.86M 116.53M 162.65M 73.61M
Income Tax - Current - Domestic
42.49M 132.82M 187.27M 86.54M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(21.63M) (16.29M) (24.61M) (12.93M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
70.67M 327.39M 444.05M 210.68M
Minority Interest Expense
- - - -
-
Net Income
70.67M 327.39M 444.05M 210.68M
Net Income Growth
-38.01% +363.30% +35.63% -52.56%
Net Margin Growth
+2.95% +8.22% +8.47% +5.56%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
70.67M 327.39M 444.05M 210.68M
Preferred Dividends
- - - -
-
Net Income Available to Common
70.67M 327.39M 444.05M 210.68M
EPS (Basic)
1.4901 6.8656 9.9583 5.3782
EPS (Basic) Growth
-38.95% +360.75% +45.05% -45.99%
Basic Shares Outstanding
47.42M 47.69M 44.59M 39.17M
EPS (Diluted)
1.4818 6.8142 9.8964 5.3552
EPS (Diluted) Growth
-38.13% +359.86% +45.23% -45.89%
Diluted Shares Outstanding
47.69M 48.05M 44.87M 39.34M
EBITDA
248.35M 581.70M 781.28M 501.79M
EBITDA Growth
+2.37% +134.22% +34.31% -35.77%
EBITDA Margin
+10.38% +14.60% +14.90% +13.24%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 50.429
Number of Ratings 9 Current Quarters Estimate 0.488
FY Report Date 12 / 2024 Current Year's Estimate 3.043
Last Quarter’s Earnings 0.61 Median PE on CY Estimate N/A
Year Ago Earnings 8.21 Next Fiscal Year Estimate 1.633
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 9 8 9 9
Mean Estimate 0.49 0.32 3.04 1.63
High Estimates 0.60 0.42 3.16 2.04
Low Estimate 0.36 0.20 2.92 1.29
Coefficient of Variance 13.83 22.74 2.19 14.88

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 3 4 4
OVERWEIGHT 0 1 1
HOLD 5 4 5
UNDERWEIGHT 1 1 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Amn Healthcare Services Inc. - AMN

Date Name Shares Transaction Value
May 22, 2024 Douglas Zane Clark Director 5,774 Bona fide gift 0.00
Apr 24, 2024 Douglas Zane Clark Director 3,019 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 24, 2024 Sylvia Trent Adams Director 3,019 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 24, 2024 Sylvia Trent Adams Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 24, 2024 Sylvia Trent Adams Director 5,453 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 24, 2024 Daphne E. Jones Director 3,019 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 24, 2024 Martha H. Marsh Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 24, 2024 Martha H. Marsh Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 24, 2024 Martha H. Marsh Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 24, 2024 Martha H. Marsh Director 56,029 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 24, 2024 Martha H. Marsh Director 33,454 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 24, 2024 Martha H. Marsh Director 27,179 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 24, 2024 Teri G. Fontenot Director 3,019 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 24, 2024 Jeff Harris Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 24, 2024 Jeff Harris Director 3,019 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 24, 2024 Jeff Harris Director 55,918 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 24, 2024 Mark G. Foletta Director 3,019 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 24, 2024 Mark G. Foletta Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 24, 2024 Mark G. Foletta Director 10,254 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 24, 2024 Douglas Zane Clark Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Amn Healthcare Services Inc. in the News